-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WusYN8pDqmuEMNwI7b1bGGwdHgSr9M6wEX3l9C4eFcloEtMG+Fm7NaHyJg8Pw0Wh X1LimkvaX8SWw7v4kMPTNQ== 0000946486-06-000010.txt : 20060105 0000946486-06-000010.hdr.sgml : 20060105 20060105164324 ACCESSION NUMBER: 0000946486-06-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060103 FILED AS OF DATE: 20060105 DATE AS OF CHANGE: 20060105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHABER CHRISTOPHER CENTRAL INDEX KEY: 0001068029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26422 FILM NUMBER: 06513400 BUSINESS ADDRESS: STREET 1: C/O DISCOVERY LABORATORIES INC STREET 2: 3359 DURHAM ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2157943064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 BUSINESS PHONE: 2154889300 MAIL ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-01-03 0 0000946486 DISCOVERY LABORATORIES INC /DE/ DSCO 0001068029 SCHABER CHRISTOPHER DISCOVERY LABORATORIES, INC. 2600 KELLY ROAD, SUITE 100 WARRINGTON PA 18976-3646 0 1 0 0 Exec. VP & COO Common Stock 2005-07-21 5 A 0 E 271 6.461 A 223500 D Common Stock 2005-10-21 5 A 0 E 271 6.45 A 223771 D Common Stock 2006-01-03 4 A 0 9000 0 A 232771 D Incentive Stock Option (right to buy) 7.01 2006-01-03 4 A 0 51222 0 A 2006-01-03 2016-01-03 Common Stock 51222 51222 D Non-Qualified Stock Option (right to buy) 7.01 2006-01-03 4 A 0 3778 0 A 2006-01-03 2016-01-03 Common Stock 3778 3778 D Transaction reported on Table I represents Issuer's matching stock contribution pursuant to 401(k) plan. New restricted stock award shall fully vest on the date that Surfaxin for RDS first becomes widely commercially available, as such date is determined by the Company. This employee stock option shall vest 25% on the date of the grant, and the balance shall vest in a series of three successive equal annual installments beginning with the first year anniversary of the grant. Christopher J. Schaber 2006-01-05 -----END PRIVACY-ENHANCED MESSAGE-----